Avandia News
Most Popular Avandia Story
GSK's Avandia trial faces recruitment battle
GlaxoSmithKline is having trouble recruiting subjects for the FDA-mandated trial of its beleaguered diabetes drug, Avandia. But not necessarily for its health risks. The pharma giant has closed two Read more...
Latest Headlines
- September 10, 2010
- July 16, 2010
- July 5, 2010
- May 31, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
